You are here

Cell Syst DOI:10.1016/j.cels.2022.08.003

Virtual screening for small-molecule pathway regulators by image-profile matching.

Publication TypeJournal Article
Year of Publication2022
AuthorsRohban, MH, Fuller, AM, Tan, C, Goldstein, JT, Syangtan, D, Gutnick, A, DeVine, A, Nijsure, MP, Rigby, M, Sacher, JR, Corsello, SM, Peppler, GB, Bogaczynska, M, Boghossian, A, Ciotti, GE, Hands, AT, Mekareeya, A, Doan, M, Gale, JP, Derynck, R, Turbyville, T, Boerckel, JD, Singh, S, Kiessling, LL, Schwarz, TL, Varelas, X, Wagner, FF, Kafri, R, Eisinger-Mathason, TSKarin, Carpenter, AE
JournalCell Syst
Date Published2022 Sep 01
ISSN2405-4720
Abstract

Identifying the chemical regulators of biological pathways is a time-consuming bottleneck in developing therapeutics and research compounds. Typically, thousands to millions of candidate small molecules are tested in target-based biochemical screens or phenotypic cell-based screens, both expensive experiments customized to each disease. Here, our uncustomized, virtual, profile-based screening approach instead identifies compounds that match to pathways based on the phenotypic information in public cell image data, created using the Cell Painting assay. Our straightforward correlation-based computational strategy retrospectively uncovered the expected, known small-molecule regulators for 32% of positive-control gene queries. In prospective, discovery mode, we efficiently identified new compounds related to three query genes and validated them in subsequent gene-relevant assays, including compounds that phenocopy or pheno-oppose YAP1 overexpression and kill a Yap1-dependent sarcoma cell line. This image-profile-based approach could replace many customized labor- and resource-intensive screens and accelerate the discovery of biologically and therapeutically useful compounds.

DOI10.1016/j.cels.2022.08.003
Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36057257?dopt=Abstract

Alternate JournalCell Syst
PubMed ID36057257